Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples